Kunz P, Caplin ME, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Demange A, Mutevelic S, Strosberg JR, Krenning EP (2021)
Publication Type: Conference contribution
Publication year: 2021
Publisher: SPRINGER
City/Town: NEW YORK
Pages Range: S188-S188
Conference Proceedings Title: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
APA:
Kunz, P., Caplin, M.E., Ruszniewski, P.B., Bodei, L., Hendifar, A., Mittra, E.,... Krenning, E.P. (2021). The Phase 3 NETTER-1 Study of [Lu-177]Lu-DOTA-TATE in Patients with Midgut Neuroendocrine Tumours: Final Overall Survival and Long-Term Renal Safety. In EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (pp. S188-S188). NEW YORK: SPRINGER.
MLA:
Kunz, P., et al. "The Phase 3 NETTER-1 Study of [Lu-177]Lu-DOTA-TATE in Patients with Midgut Neuroendocrine Tumours: Final Overall Survival and Long-Term Renal Safety." Proceedings of the EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING NEW YORK: SPRINGER, 2021. S188-S188.
BibTeX: Download